Chicago, Illinois
Colorectal cancer clinical trials in Chicago, IL
53 colorectal cancer studies are recruiting participants at sites in Chicago as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Chicago at a glance
- 53 studies are recruiting at a site in Chicago.
- By phase: Phase 1 (8), Phase 1/2 (8), Phase 2 (7), Phase 2/3 (2), Phase 3 (9), Phase 4 (1), No phase (8), Observational (10). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (27), university, hospital or other (26).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Chicago
Basic details from each study's public record (the 30 most recently updated of 53). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study sites
- Northwestern Medicine Cancer Center Old Irving Park · Northwestern University · University of Chicago Comprehensive Cancer Center
- Registry record
- NCT05863195 · updated
Shield Post-Approval Study Protocol
- Observational
- Ages 45 to 81
- All sexes
- Sponsor
- Guardant Health, Inc.
- Study site
- GI Solutions of Illinois
- Registry record
- NCT06880055 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- John H Stroger Jr Hospital of Cook County
- Registry record
- NCT03998202 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Study site
- Northwestern Memorial Hospital
- Registry record
- NCT07446322 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- John H Stroger Jr Hospital of Cook County
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Advocate Illinois Masonic Medical Center · John H Stroger Jr Hospital of Cook County · Mount Sinai Hospital Medical Center
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Advocate Illinois Masonic Medical Center · John H Stroger Jr Hospital of Cook County · Mount Sinai Hospital Medical Center
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Advocate Illinois Masonic Medical Center · John H Stroger Jr Hospital of Cook County
- Registry record
- NCT06418204 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Advocate Illinois Masonic Medical Center
- Registry record
- NCT07283939 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- University of Illinois
- Registry record
- NCT05673148 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Advocate Illinois Masonic Medical Center
- Registry record
- NCT07143487 · updated
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- The University of Chicago Medical Center
- Registry record
- NCT07416552 · updated
FITting Non-invasive Tests in Lynch Syndrome Surveillance
- No phase
- Ages 20 to 80
- All sexes
- Sponsor
- University of Chicago
- Study site
- The University of Chicago Medical Center
- Registry record
- NCT06898996 · updated
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- University of Illinois Cancer Center
- Registry record
- NCT07284849 · updated
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University of Chicago Medical Center /ID# 271688
- Registry record
- NCT06820463 · updated
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- University of Chicago Medical Center
- Registry record
- NCT07221357 · updated
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Delcath Systems Inc.
- Study site
- Northwestern University - Feinberg School of Medicine
- Registry record
- NCT06607458 · updated
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University of Chicago Medical Center /ID# 279365
- Registry record
- NCT07525206 · updated
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- City of Hope at Illinois Chicago Downtown
- Registry record
- NCT07595874 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study sites
- Northwestern Medicine Cancer Center · The University of Chicago
- Registry record
- NCT06526819 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- University of Chicago Medical Center /ID# 274742
- Registry record
- NCT07023289 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Illinois Cancer Specialists
- Registry record
- NCT07222800 · updated
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Avacta Life Sciences Ltd
- Study site
- The University of Chicago
- Registry record
- NCT07454642 · updated
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- No phase
- Ages 65 to 82
- All sexes
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study site
- Northwestern Memorial Hospital
- Registry record
- NCT05612347 · updated
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Exelixis Clinical Site #26
- Registry record
- NCT05176483 · updated
PRE-ISPY Phase I/II Oncology Platform Program
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- QuantumLeap Healthcare Collaborative
- Study site
- The University of Chicago Medicine Comprehensive Cancer Center
- Registry record
- NCT05868226 · updated
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- University of Chicago
- Study site
- University of Chicago
- Registry record
- NCT06349590 · updated
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- University of Chicago
- Registry record
- NCT06253871 · updated
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Amgen
- Study site
- Insight Research Institute
- Registry record
- NCT06252649 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Chicago, IL on ClinicalTrials.gov.
Ask about studies near Chicago
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections